Irilieva 100mg

Irilieva 100mg injection is classified as an anti-cancer medication, also known as a cytostatic. Its active component is Irinotecan hydrochloride trihydrate. This medication is indicated for adults with advanced colon and rectal cancer. It may be administered alone or in conjunction with other chemotherapy drugs. Colon and rectal cancers are most commonly found in individuals over the age of 50, with their occurrence influenced by both genetic and environmental factors.

The most frequently reported side effects of this medication include myelosuppression (which results in reduced levels of red blood cells, white blood cells, and platelets) and diarrhea. Other common adverse reactions associated with Irilieva 100mg injection encompass nausea, vomiting, abdominal discomfort, constipation, anemia, pain, fatigue, fever, infections such as sepsis, elevated bilirubin levels, hair loss, and weight reduction. It is essential to inform your doctor if these side effects are bothersome or persist. Additionally, notify your healthcare provider if you have a history of chronic inflammatory bowel disease, bowel obstruction, or if you have received any live vaccines.

If you have an allergy to Irinotecan or any of its components, inform your physician. Prior to initiating treatment, disclose any liver issues, jaundice, kidney or heart conditions, asthma, high blood pressure, high cholesterol, or severe diarrhea to your doctor. If you smoke or have previously undergone radiation therapy, it is important to inform your healthcare provider. Consult with your healthcare provider regarding any other medications, herbs, or supplements you may be taking. It is crucial for both males and females to use effective contraception during treatment to prevent pregnancy. Your physician will conduct blood tests before and during treatment to monitor the impact of Irilieva 100mg injection on blood counts and chemistry.